Timothy Coughlin
CIK 1376043 · Chief Financial Officer · last filed 2026-06-10
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$26.12M
Companies
8
Total Filings
82
Lifetime Open-Market Net
-$12.99M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| VIR | Director | 8,000 | $8.61 | $68.9K | $0 | 1 | 2026-06-10 |
| ADCT | Director | 72,400 | $1.05 | $76.0K | $0 | 2 | 2026-06-03 |
| TVTX | Director | 56,250 | $52.04 | $2.93M | -$771.9K | 8 | 2026-05-21 |
| ATYR | Director | — | $0.44 | — | $0 | 1 | 2026-05-13 |
| LIFE | Director | 56,000 | $15.61 | $874.2K | $87.5K | 12 | 2025-05-02 |
| FATE | Director | 66,282 | $2.06 | $136.5K | $117.2K | 12 | 2024-06-11 |
| Travere Therapeutics, Inc. (RTRX) Delisted | Director | 32,000 | — | — | $0 | 6 | 2020-05-19 |
| NBIX | Chief Financial Officer | 137,961 | $159.76 | $22.04M | -$12.42M | 40 | 2017-02-08 |
Recent Filings · Page 4 of 9
82 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2018-05-17 | LIFE | Grant (A) | — | $0 | EDGAR |
| 2018-05-11 | Travere Therapeutics, Inc. (RTRX) Delisted | Grant (A) | +2,500 | $0 | EDGAR |
| 2018-05-04 | FATE | Grant (A) | — | $0 | EDGAR |
| 2017-05-18 | Travere Therapeutics, Inc. (RTRX) Delisted | Grant (A) | +2,500 | $0 | EDGAR |
| 2017-05-11 | LIFE | Grant (A) | — | $0 | EDGAR |
| 2017-05-04 | FATE | Grant (A) | — | $0 | EDGAR |
| 2017-04-10 | LIFE | Grant (A) | — | $0 | EDGAR |
| 2017-02-08 | NBIX | Sell (S) | −963 | -$41.5K | EDGAR |
| 2017-02-06 | NBIX | Sell (S) | −1,500 | -$63.8K | EDGAR |
| 2017-01-18 | NBIX | Sell (S) | −1,750 | -$71.1K | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.